Pilot study of plasma creatine riboside as a potential biomarker for cervical cancer

This pilot study aimed primarily to evaluate plasma levels of a novel metabolite, creatine riboside, in patients with cervical cancer (discovery and validation cohorts, n = 11 for each) compared with non-cancer subjects (controls, n = 30). We found that the pre-treatment plasma creatine riboside lev...

Descripción completa

Detalles Bibliográficos
Autores principales: Oike, Takahiro, Osu, Naoto, Yoshimoto, Yuya, Obinata, Hideru, Yoshikawa, Kazuhiro, Harris, Curtis C., Ohno, Tatsuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10245246/
https://www.ncbi.nlm.nih.gov/pubmed/37292314
http://dx.doi.org/10.1016/j.heliyon.2023.e16684

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10245246/
https://www.ncbi.nlm.nih.gov/pubmed/37292314
http://dx.doi.org/10.1016/j.heliyon.2023.e16684

Ejemplares similares